HeyJaredDan Schell
- Indexed articles, last 90 days
- 24
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Clinicalleader
- Top 5M sites
- Earliest in this view
- Jul 7, 2026
Latest articles
With CROs, Decide What You Can Actually Manage (opens the original)
Read excerpt
By Dan Schell, Chief Editor, Clinical Leader Peter Fredette and I spent the first 10 minutes of our interview talking about music. We’re both musicians, and although we had never spoken before, that discovery sent us down a rabbit hole before I finally remembered I was supposed to be interviewing him about CROs. As it turned out, the detour probably helped. Once we got around to clinical trials, the conversation felt less like an interview and more like two people pulling apart an industry model
09.30.26 -- Old Trial Playbooks Are Breaking Under New Complexity (opens the original)
Read excerpt
Join our webinar on October 22, 2026, at 11 AM ET to learn how to successfully execute adaptive trials. We will explore key impacts on sites, data, technology, supply, and teams. Don't let adaptation turn into disruption—register today to secure your spot! Registration is free. The Rare Trials Summit Wants To Produce More Than Conversation From The Editor | By Dan Schell, Chief Editor, Clinical Leader The Rare Trials Summit returns to Boston this September with a mission that extends beyond trad
09.29.26 -- Sponsors Are Rethinking Payments, eSource, And Study Design — Are You? (opens the original)
Read excerpt
From The Editor | By Dan Schell, Chief Editor, Clinical Leader Regeneron’s Kaniel Cassady argues that “doing more with less” in clinical development should start with questioning existing processes, unnecessary data collection, and outdated workflows before turning to AI and other new technologies. The New Reality Of Clinical Trial Payment Workflows Outdated trial payment processes create costly delays. Explore strategies for centralized financial management, participant reimbursement, and impro
Small Biotech Can Outsource The Work, But Not The Thinking (opens the original)
Read excerpt
By Dan Schell, Chief Editor, Clinical Leader I’ve known Robert Goldman for about three years, and if you’ve ever met him, you probably know that asking him a question rarely produces a cautious, carefully hedged answer. That’s one of the reasons I enjoy talking with him. Goldman, VP of clinical development at Contraline, recently took that same approach to the stage at OCT Southern California. Contraline is developing a long-lasting, non-hormonal contraceptive for men, and Goldman is now prepari
09.22.26 -- Sponsors Take Control: Faster Builds, Cleaner Data, Audit-Ready Trials (opens the original)
Read excerpt
What SIP Gets Right And Where It Still Falls Short From The Editor | By Dan Schell, chief editor, Clinical Leader SIP users Sophie Haynes and Vicki Alvarez identify features that provide value but question whether the platform eliminates enough work to justify its setup demands, repetitive processes, and usability challenges. Why More Sponsors Are Taking Control Of Clinical Trial Study Builds Accelerate study startup and reduce rework by building studies directly in EDC. Discover a more flexible
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 5M sites
For Clinicalleader, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.